tiprankstipranks
RegenXBio (RGNX)
NASDAQ:RGNX
US Market
RGNX
RegenXBio
RESEARCH TOOLSreports

RegenXBio (RGNX) Income Statement

1,071 Followers

RegenXBio Income Statement

Last quarter (Q4 2025), RegenXBio's total revenue was $30.34M, an increase of 43.00% from the same quarter last year. In Q4, RegenXBio's net income was $-67.15M. See RegenXBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 170.44M$ 83.33M$ 90.24M$ 112.72M$ 470.35M
Gross Profit
$ 150.14M$ 49.76M$ 53.03M$ 58.18M$ 418.51M
Operating Expenses
$ 311.34M$ 283.11M$ 321.16M$ 321.06M$ 258.53M
Depreciation and Amortization
$ 15.62M$ 16.21M$ 17.32M$ 12.91M$ 9.56M
EBITDA
$ -145.58M$ -198.23M$ -239.46M$ -244.24M$ 169.54M
Operating Income
$ -161.20M$ -233.35M$ -268.13M$ -262.88M$ 159.98M
Other Income/Expenses
$ -32.68M$ 6.24M$ 4.48M$ -17.53M$ -18.73M
Pretax Income
$ -193.88M$ -227.10M$ -263.65M$ -280.40M$ 141.25M
Net Income
$ -193.88M$ -227.10M$ -263.49M$ -280.32M$ 127.84M
Per Share Metrics
Basic EPS
$ -3.76$ -4.59$ -6.02$ -6.50$ 3.01
Diluted EPS
$ -3.76$ -4.59$ -6.02$ -6.50$ 2.91
Weighted Average Shares Outstanding
 51.57M 49.51M 43.73M 43.15M 42.44M
Weighted Average Shares Outstanding (Diluted)
 51.57M 49.51M 43.73M 43.15M 43.91M
Currency in USD

RegenXBio Earnings and Revenue History